WASHINGTON (AP) — The Supreme Court on Thursday ruled that makers of generic drugs cannot be sued for failing to warn consumers of the possible side effects of their products if they copy the exact warnings on the medicines' brand-name equivalents.
The majority opinion acknowledged that the decision dealt an "unfortunate hand" that "makes little sense" to those who were harmed by generic drugs and are unable to sue the drugmakers.
A sharply divided court decided in a 5-4 judgment that the federal law requiring generics to have the same warnings as their brand name equivalents trumps state laws that allow people to sue drug companies that fail to present proper warnings for their products.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
